RLAY vs SNDL · rev $3.4M vs $357.7M cap
Relay Therapeutics Inc (RLAY) versus SNDL Inc. (SNDL) — a side-by-side from cached financials, not a winner call.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
SNDL Inc. (SNDL) is a beverages - wineries & distilleries company listed on US.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
SNDL does not have a complete income-statement cache yet.
RLAY currently screens at market cap $3.39B. SNDL currently screens at market cap $357.7M.
Not investment advice. Open the RLAY and SNDL stock pages for the full models.
Not investment advice.